Ginkgo signs deal worth up to $406M with Boehringer Ingelheim
Pharmaceutical giant Boehringer Ingelheim has hired Ginkgo Bioworks to help discover new drugs going after historically "undruggable" targets.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Rowan Walrath Source Type: news
More News: Ginkgo | Health Management